Sobi hires Alan Raffensperger as COO
This article was originally published in Scrip
Executive Summary
Swedish Orphan Biovitrum has appointed Alan Raffensperger chief operating officer. Mr Raffensperger was most recently CEO of Benechill, a US-based medical device company. Prior to that, he served as executive director and head of nephrology at Amgen. He will report to CEO Geoffrey McDonough.